Parkwood LLC’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-528
| Closed | -$31K | – | 85 |
|
|
2024
Q2 | $31K | Buy |
528
+21
| +4% | +$1.23K | ﹤0.01% | 125 |
|
|
2024
Q1 | $524K | Buy |
507
+56
| +12% | +$57.9K | 0.05% | 156 |
|
|
2023
Q4 | $357K | Sell |
451
-139
| -24% | -$110K | 0.04% | 105 |
|
|
2023
Q3 | $280K | Sell |
590
-62
| -10% | -$29.4K | 0.03% | 112 |
|
|
2023
Q2 | $392K | Sell |
652
-87
| -12% | -$52.3K | 0.07% | 113 |
|
|
2023
Q1 | $522K | Buy |
739
+152
| +26% | +$107K | 0.07% | 108 |
|
|
2022
Q4 | $602K | Sell |
587
-23
| -4% | -$23.6K | 0.09% | 102 |
|
|
2022
Q3 | $354K | Sell |
610
-316
| -34% | -$183K | 0.05% | 121 |
|
|
2022
Q2 | $507K | Buy |
+926
| New | +$507K | 0.09% | 107 |
|
|
2022
Q1 | – | Sell |
-1,062
| Closed | -$438K | – | 131 |
|
|
2021
Q4 | $438K | Sell |
1,062
-311
| -23% | -$128K | 0.07% | 97 |
|
|
2021
Q3 | $1.01M | Buy |
+1,373
| New | +$1.01M | 0.12% | 92 |
|